{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Hormone parathyroïdienne : Questions médicales les plus fréquentes",
"headline": "Hormone parathyroïdienne : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Hormone parathyroïdienne : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-19",
"dateModified": "2026-03-11",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Hormone parathyroïdienne"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Hormones peptidiques",
"url": "https://questionsmedicales.fr/mesh/D036361",
"about": {
"@type": "MedicalCondition",
"name": "Hormones peptidiques",
"code": {
"@type": "MedicalCode",
"code": "D036361",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.644.548"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Tériparatide",
"alternateName": "Teriparatide",
"url": "https://questionsmedicales.fr/mesh/D019379",
"about": {
"@type": "MedicalCondition",
"name": "Tériparatide",
"code": {
"@type": "MedicalCode",
"code": "D019379",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.644.548.587.850"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Hormone parathyroïdienne",
"alternateName": "Parathyroid Hormone",
"code": {
"@type": "MedicalCode",
"code": "D010281",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Philipp Riss",
"url": "https://questionsmedicales.fr/author/Philipp%20Riss",
"affiliation": {
"@type": "Organization",
"name": "Division of Visceral Surgery, Department of General Surgery, Medical University of Vienna, Vienna, Austria."
}
},
{
"@type": "Person",
"name": "Zhuowen Hao",
"url": "https://questionsmedicales.fr/author/Zhuowen%20Hao",
"affiliation": {
"@type": "Organization",
"name": "Department of Spine Surgery and Musculoskeletal Tumor, Zhongnan Hospital, Wuhan University, Wuhan 430071, P.R.China."
}
},
{
"@type": "Person",
"name": "Jingfeng Li",
"url": "https://questionsmedicales.fr/author/Jingfeng%20Li",
"affiliation": {
"@type": "Organization",
"name": "Department of Spine Surgery and Musculoskeletal Tumor, Zhongnan Hospital, Wuhan University, Wuhan 430071, P.R.China."
}
},
{
"@type": "Person",
"name": "Lindsay Hargitai",
"url": "https://questionsmedicales.fr/author/Lindsay%20Hargitai",
"affiliation": {
"@type": "Organization",
"name": "Division of Visceral Surgery, Department of General Surgery, Medical University of Vienna, Vienna, Austria."
}
},
{
"@type": "Person",
"name": "Daniela Dunkler",
"url": "https://questionsmedicales.fr/author/Daniela%20Dunkler",
"affiliation": {
"@type": "Organization",
"name": "Section for Clinical Biometrics, Centre for Medical Statistics, Informatics and Intelligent Systems, Medical University of Vienna, Vienna, Austria."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Parathyroid fine-needle aspiration with parathyroid hormone washout as a preoperative localisation of parathyroid adenoma-A retrospective study.",
"datePublished": "2023-06-07",
"url": "https://questionsmedicales.fr/article/37287384",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/cen.14939"
}
},
{
"@type": "ScholarlyArticle",
"name": "Utility of parathyroid hormone immunocytochemistry in fine needle aspiration diagnosis of parathyroid tissue.",
"datePublished": "2023-08-03",
"url": "https://questionsmedicales.fr/article/37534757",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/cyt.13283"
}
},
{
"@type": "ScholarlyArticle",
"name": "The Relationship Between Atrial Fibrillation and Parathyroid Hormone in Heart Failure Outpatients.",
"datePublished": "2023-09-30",
"url": "https://questionsmedicales.fr/article/37815140",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.18087/cardio.2023.9.n2277"
}
},
{
"@type": "ScholarlyArticle",
"name": "Case report: Familial hypoparathyroidism with elevated parathyroid hormone due to an inactivating",
"datePublished": "2024-10-07",
"url": "https://questionsmedicales.fr/article/39435356",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fendo.2024.1415639"
}
},
{
"@type": "ScholarlyArticle",
"name": "Association of defects of enamel with polymorphisms in the vitamin D receptor and parathyroid hormone genes.",
"datePublished": "2024-06-24",
"url": "https://questionsmedicales.fr/article/38922252",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1590/0103-6440202405900"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides aminés, peptides et protéines",
"item": "https://questionsmedicales.fr/mesh/D000602"
},
{
"@type": "ListItem",
"position": 3,
"name": "Peptides",
"item": "https://questionsmedicales.fr/mesh/D010455"
},
{
"@type": "ListItem",
"position": 4,
"name": "Hormones peptidiques",
"item": "https://questionsmedicales.fr/mesh/D036361"
},
{
"@type": "ListItem",
"position": 5,
"name": "Hormone parathyroïdienne",
"item": "https://questionsmedicales.fr/mesh/D010281"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Hormone parathyroïdienne - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Hormone parathyroïdienne",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-05-08",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Hormone parathyroïdienne",
"description": "Comment diagnostiquer un déséquilibre de la PTH ?\nQuels symptômes indiquent un excès de PTH ?\nQuels tests sont utilisés pour évaluer la PTH ?\nQuand faut-il vérifier les niveaux de PTH ?\nQuel rôle joue la PTH dans le diagnostic des maladies ?",
"url": "https://questionsmedicales.fr/mesh/D010281#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Hormone parathyroïdienne",
"description": "Quels sont les symptômes d'une carence en PTH ?\nComment l'excès de PTH affecte-t-il le corps ?\nQuels signes cliniques sont associés à l'hyperparathyroïdie ?\nQuels symptômes osseux sont liés à la PTH ?\nComment la PTH influence-t-elle l'humeur ?",
"url": "https://questionsmedicales.fr/mesh/D010281#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Hormone parathyroïdienne",
"description": "Comment prévenir l'hyperparathyroïdie ?\nQuels examens préventifs sont recommandés ?\nComment éviter les carences en PTH ?\nQuels facteurs de mode de vie influencent la PTH ?\nLa prévention des maladies osseuses est-elle liée à la PTH ?",
"url": "https://questionsmedicales.fr/mesh/D010281#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Hormone parathyroïdienne",
"description": "Quels traitements existent pour l'hyperparathyroïdie ?\nComment traiter une carence en PTH ?\nQuels médicaments régulent la PTH ?\nLa chirurgie est-elle nécessaire pour la PTH ?\nQuels changements alimentaires aident à la PTH ?",
"url": "https://questionsmedicales.fr/mesh/D010281#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Hormone parathyroïdienne",
"description": "Quelles complications peuvent survenir avec l'hyperparathyroïdie ?\nComment l'hypercalcémie affecte-t-elle la santé ?\nQuels risques sont associés à une carence en PTH ?\nL'hyperparathyroïdie peut-elle causer des problèmes mentaux ?\nQuelles sont les complications à long terme de l'hyperparathyroïdie ?",
"url": "https://questionsmedicales.fr/mesh/D010281#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Hormone parathyroïdienne",
"description": "Quels sont les facteurs de risque de l'hyperparathyroïdie ?\nLe sexe influence-t-il le risque de PTH ?\nCertaines maladies augmentent-elles le risque de PTH ?\nLe mode de vie influence-t-il la PTH ?\nL'hérédité joue-t-elle un rôle dans les troubles de la PTH ?",
"url": "https://questionsmedicales.fr/mesh/D010281#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer un déséquilibre de la PTH ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sanguins mesurant les niveaux de PTH et de calcium sont effectués."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent un excès de PTH ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fatigue, douleurs osseuses, et calculs rénaux peuvent signaler un excès de PTH."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer la PTH ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les dosages de PTH, calcium et phosphore dans le sang sont courants."
}
},
{
"@type": "Question",
"name": "Quand faut-il vérifier les niveaux de PTH ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Lors de symptômes d'hypercalcémie ou de maladies osseuses suspectées."
}
},
{
"@type": "Question",
"name": "Quel rôle joue la PTH dans le diagnostic des maladies ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle aide à identifier les troubles du métabolisme calcique et osseux."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une carence en PTH ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Crampes musculaires, engourdissements et spasmes peuvent survenir."
}
},
{
"@type": "Question",
"name": "Comment l'excès de PTH affecte-t-il le corps ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il peut entraîner une hypercalcémie, des douleurs osseuses et des calculs rénaux."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques sont associés à l'hyperparathyroïdie ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Nausées, vomissements, fatigue et dépression peuvent être présents."
}
},
{
"@type": "Question",
"name": "Quels symptômes osseux sont liés à la PTH ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les douleurs osseuses et les fractures fréquentes peuvent indiquer un problème."
}
},
{
"@type": "Question",
"name": "Comment la PTH influence-t-elle l'humeur ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des niveaux anormaux de PTH peuvent contribuer à des troubles de l'humeur."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'hyperparathyroïdie ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi médical régulier et une alimentation équilibrée aident à prévenir."
}
},
{
"@type": "Question",
"name": "Quels examens préventifs sont recommandés ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de calcium et de PTH peuvent être effectués chez les personnes à risque."
}
},
{
"@type": "Question",
"name": "Comment éviter les carences en PTH ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation riche en calcium et en vitamine D est essentielle."
}
},
{
"@type": "Question",
"name": "Quels facteurs de mode de vie influencent la PTH ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le tabagisme et l'alcool peuvent affecter les niveaux de PTH."
}
},
{
"@type": "Question",
"name": "La prévention des maladies osseuses est-elle liée à la PTH ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, maintenir des niveaux sains de PTH aide à prévenir les maladies osseuses."
}
},
{
"@type": "Question",
"name": "Quels traitements existent pour l'hyperparathyroïdie ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "La chirurgie, les médicaments et les changements alimentaires sont des options."
}
},
{
"@type": "Question",
"name": "Comment traiter une carence en PTH ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des suppléments de calcium et de vitamine D sont souvent prescrits."
}
},
{
"@type": "Question",
"name": "Quels médicaments régulent la PTH ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les bisphosphonates et les calcimimétiques peuvent être utilisés."
}
},
{
"@type": "Question",
"name": "La chirurgie est-elle nécessaire pour la PTH ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, en cas de tumeur parathyroïdienne ou d'hyperparathyroïdie sévère."
}
},
{
"@type": "Question",
"name": "Quels changements alimentaires aident à la PTH ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation riche en calcium et en vitamine D est recommandée."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec l'hyperparathyroïdie ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications comme l'ostéoporose et les calculs rénaux peuvent se développer."
}
},
{
"@type": "Question",
"name": "Comment l'hypercalcémie affecte-t-elle la santé ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut entraîner des problèmes rénaux, cardiaques et neurologiques."
}
},
{
"@type": "Question",
"name": "Quels risques sont associés à une carence en PTH ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des convulsions, des spasmes musculaires et des troubles cardiaques peuvent survenir."
}
},
{
"@type": "Question",
"name": "L'hyperparathyroïdie peut-elle causer des problèmes mentaux ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle est liée à des troubles de l'humeur et des problèmes cognitifs."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications à long terme de l'hyperparathyroïdie ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'ostéoporose et les maladies cardiovasculaires peuvent se développer à long terme."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque de l'hyperparathyroïdie ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'âge avancé, les antécédents familiaux et certaines maladies augmentent le risque."
}
},
{
"@type": "Question",
"name": "Le sexe influence-t-il le risque de PTH ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les femmes sont plus susceptibles de développer des troubles de la PTH."
}
},
{
"@type": "Question",
"name": "Certaines maladies augmentent-elles le risque de PTH ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des maladies comme le syndrome de MEN et l'insuffisance rénale sont des facteurs de risque."
}
},
{
"@type": "Question",
"name": "Le mode de vie influence-t-il la PTH ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme et une mauvaise alimentation peuvent augmenter le risque."
}
},
{
"@type": "Question",
"name": "L'hérédité joue-t-elle un rôle dans les troubles de la PTH ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de maladies parathyroïdiennes augmentent le risque."
}
}
]
}
]
}
Department of Nephrology, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University; The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, PR China.
Key Laboratory of Shenzhen Renal Diseases, Shenzhen, PR China.
Department of Nephrology, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University; The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, PR China.
Key Laboratory of Shenzhen Renal Diseases, Shenzhen, PR China.
Research Center for Human Tissue and Organs Degeneration, Institute of Biomedicine and Biotechnology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, PR China.
University of Chinese Academy of Sciences, Beijing, PR China.
5th department of Internal Medicine, Comenius University Faculty of Medicine, University Hospital Bratislava, Bratislava, Slovakia. martin.kuzma@fmed.uniba.sk.
The use of parathyroid lesion aspiration in preoperative adenoma localisation is controversial. Concerns have been raised regarding both immediate safety (hematoma, infection, alterations on a subsequ...
A retrospective study....
The sample comprised 29 patients with primary hyperparathyroidism who underwent minimally invasive parathyroidectomy at a tertiary referral centre, following localisation with parathyroid hormone wash...
We reviewed all parathyroid hormone washout procedures performed during 2011-2021. Clinical, biochemical, and imaging information; and cytology, surgery, and pathology reports were extracted from elec...
Parathyroid hormone levels from the needle wash were 2.1-112.5 times the upper limit of the serum norm. Other than mild neck discomfort, no immediate procedure complications were documented. Fibrotic ...
Parathyroid fine-needle aspiration with parathyroid hormone washout was accurate. Immediate, surgical, or delayed complications were not demonstrated in our series. This approach might be considered f...
The cytomorphological features of parathyroid tissue (PTT) may overlap with those of thyroid lesions, thus posing a diagnostic challenge. In this retrospective study, we reviewed our institutional exp...
Our pathology database was searched for FNA cases in which PTH ICC was performed between 1 January 2015 and 31 March 2022. PTH ICC was performed on a ThinPrep slide in cases with a clinical suspicion ...
The study cohort included 103 cases clinically designated as thyroid (n = 85, 82.5%), parathyroid (n = 11, 10.7%) and neck soft tissue (n = 7, 6.8%). PTH immunostaining was negative, positive, and ind...
Our study demonstrates that PTH ICC performed on additional ThinPrep slides is a valuable adjunct test in FNA samples with a differential diagnosis of PTT vs non-PTT. Low cellularity may be a limiting...
Background Atrial fibrillation (AF) is a common arrhythmia in heart failure (HF). Plasma concentrations of para-thyroid hormone (PTH) have been shown to increase in HF. The relationship between PTH co...
So far, only 11...
The proband is a 34-year-old woman who has a history of chronic severe hypocalcemia (HypoCa) since birth. She and her three brothers (33-year-old male twins, and a 21-year-old male) were diagnosed wit...
WES showed no pathogenic, likely pathogenic or variants of unknown significance in any known calcium-associated genetic disorder but a bi-allelic variant in the...
Because the patient's HypoCa was not controlled on large doses of calcitriol and calcium carbonate, a trial of teriparatide 20 mcg SC daily was started and resulted in normalization of calcium, declin...
High PTH in the presence of congenital hypocalcemia is not always due to receptor or post-receptor defect and can be due to a biologically inactive mutated PTH. In such cases, treatment with teriparat...
This cross-sectional study aimed to investigate the association between developmental defects of enamel (DDE) and single nucleotide polymorphisms (SNPs) in the genes encoding the vitamin D receptor (V...
Patients with kidney failure experience derangements of circulating markers of mineral metabolism and dysregulation of skeletal and cardiovascular physiology which results in high mortality rate in th...
In this randomized controlled trial conducted in an HD center in Iran, adult patients receiving chronic HD were randomized to intradialytic exercise (60 min) in the second hour of thrice weekly dialys...
The study included 44 participants randomized to intervention (n = 22) or control (n = 22). During the 6-month intervention period, significant between-group changes were observed in all primary and s...
Intradialytic exercise performed for at least 60 min during thrice weekly dialysis sessions improves bone mineral metabolism in adult patients receiving HD. Further studies should focus on observing a...
ClinicalTrials.gov Identifier: NCT04916743, Registered on 08/06/2021. Registered trial name: The Effect of Intradialytic Exercise on Calcium, Phosphorous and Parathyroid Hormone: A Randomized Controll...
Chronic kidney disease-mineral bone disease (CKD-MBD) is a major complication of CKD. Bone turnover markers (BTMs) are important for clinicians to evaluate and manage patients with CKD-MBD. This study...
A total of 408 subjects were included in this study. The serum BTMs including N-terminal midfragment osteocalcin (N-MID OC), β-isomerized C-terminal telopeptides (β-CTX), and total procollagen type 1 ...
BTMs was no significant difference between non-CKD and CKD stages 1, 2, and 3. However, N-MID OC, β-CTX were significantly increased in patients with CKD stage 4 compared to non-CKD patients and patie...
BTMs in advanced CKD stages were significantly higher than in the early disease stages. PTH level was independently and positively associated with the BTM levels in patients with CKD. In the advanced ...
Chronic kidney disease (CKD) is a prevalent pathological condition worldwide. Parathyroid hormone (PTH) is an important index related to bone metabolism in CKD patients and has not received enough att...
The aim of our study was to verify whether running a marathon (32nd Wroclaw Marathon) was associated with changes in sclerostin and intact PTH (iPTH) concentration in middle-aged males. We enrolled 33...